AI & Technology

UAE integrates AI and robotics to accelerate liver disease diagnosis

By 19Network Editorial Team · Nov 21, 2026 · 2 min read

A scientist in a medical lab uses a robotic arm and digital interface to analyze a synthetic human liver model.

Medical experts at the EGHS Conference 2026 in Dubai announce new AI-driven diagnostic protocols and the launch of Resmetirom to treat liver fibrosis.

The UAE has integrated artificial intelligence and robotic surgical systems into its national gastroenterology framework to accelerate the diagnosis of liver and digestive diseases, officials confirmed at a major medical summit in Dubai on Saturday, 21 November. Regulatory framework for AI adoption Dr. Yousif Mohammed Al Serkal, Director-General of Emirates Health Services (EHS), stated that the UAE’s "agile governance system" has enabled the rapid piloting of AI-based diagnostic software and devices. Speaking on the second day of the Emirates Gastroenterology and Hepatology Society (EGHS) Conference 2026, Al Serkal noted that these technologies are now being integrated into standard healthcare services under strict regulatory monitoring by federal health authorities. The move to adopt agentic AI and automated diagnostic tools is designed to identify gastrointestinal issues earlier and with higher precision than traditional methods. Al Serkal confirmed that various healthcare institutions are currently overseeing the framework that governs these software-driven diagnoses to ensure compliance with international medical standards. New treatments for liver fibrosis Medical experts at the conference announced the UAE launch of Resmetirom, a newly approved medication targeting thyroid receptors to treat metabolic dysfunction-associated steatohepatitis (MASH). Dr. Abdulla Al Hassani, President of the EGHS, confirmed that clinical data shows the drug can significantly reverse…

Source: Gulf News

Read on 19Network